Skip to main content

Doris and Alice on Big Pharma and Motorized Scooters

We had dinner with family friends Doris and Alice last night.  Doris is 90 and Alice is 91.  They have some strong opinions (they always do).  Doris and Alice gave permission for sharing their opinions on GeriPal, with their picture.
  • Big pharma is taking a hit, according to recent headlines.  Lots of drugs are going off patent and becoming generic.  Few new drugs are in the pipeline. Should we feel sorry for big pharma? Doris and Alice:  "No! We have enough drugs already."  The relentless profit incentive of big pharma drives up costs of drugs to levels that are bankrupting seniors and our economy. "They make too much money already." 
  • "Motorized scooters are a scam!"  Of course motorized scooters are a good thing for some folks who really can't walk.  But Doris and Alice find themselves bombarded with advertisements for motorized scooters.  They feel that the advertisements are disingenuous when they advertise themselves as "free" or "at no cost to you."  The cost is to our health care system, paid for by Medicare via our taxes, and these wheelchairs are never re-used.  Both are liberal politically - and still march in local rallies - but said "it makes me feel like a conservative republican to say this is fraud and abuse of our tax dollars." They also know of elders who have given up on physical therapy for the ease of getting around in a motorized scooter.  The ads imply that "anyone who wants one can have one - even if they're not disabled" They say, "intermediaries who sell these scooters are taking advantage of seniors." 
What do you think?

by: Alex Smith

Comments

Alex Smith said…
My mom who is 65 received a robo-call this morning saying, "if you or someone else in your home is on Medicare and using a cane or having mobility problems you may be eligible for a motorized scooter.". Too bad we don't have similar adds for physical therapy and walking. Outreach in and of itself isn't the problem. It's the profit that drives selected outreach of expensive devices that is problematic.
ken covinsky said…
The use and cost of motorized scooters are very difficult problems. I have always thought these devices are both vastly underused and overused.

On the one hand, their are a lot of patients who have very serious mobility problems who would get enourmous benefit. They refuse the soooter becasue they are afraid to acknowledge their mobilty problem, or because it is not offered to them. I have seen a number of patients have their life space mobilty restored with scooters.

On the other hand, the promotion and marketing of soooters is scandolous. The companies are very aggressive. The marketing is not based on doing good for patients but on extracting $$ from Medicare.

It is a shame Medicare is not allowed to negotiate for the best price on scooters. One wonders how much the price would fall if the soooter companies had to compete based on price and quality. Seems like a great opportunity to let free markets work.
Dan Matlock said…
Ken's points are well said - knowing who benefits from a scooter (in terms of increased mobility and a broader world) vs. who is harmed by a scooter (in terms of accelerated functional decline from losing the only exercise they were getting) is a vexing geriatric challenge.
Lynn O'Neill said…
I love that you had dinner with Doris and Alice. We all need a Doris and Alice in our lives with whom we can have intergenerational conversation away from our workplace!
Margo Smith said…
This from Doris and Alice themselves, reflecting on the original blog post during lunch today, 6/25/11.

Alice recalls the line from scooter commercials that scooters will be "paid in full," but wonders why each of these perfectly usable (and well compensated) devices must be discarded in favor of new sales when they are no longer needed by their owners. Is there no market for used ones?

Doris has noticed recently that scooter producers have lessened their advertising. She wonders whether these companies are embarrassed by attention to their suggestion that consumers can game the Medicare system.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Opening the Black Box of LTACs: Podcast with Anil Makam

What happens in Long Term Acute Care Hospitals, or LTACs (pronounced L-tacs)?  I've never been in one.  I've sent patients to them - usually patients with long ICU stays, chronically critically ill, with a gastric feeding tube and a trach for ventilator support.  For those patients, the goals (usually as articulated by the family) are based on a hope for recovery of function and a return home.

And yet we learn some surprising things from Anil Makam, Assistant Professor of Medicine at UCSF.  In his JAGS study of about 14,000 patients admitted to LTACHs, the average patient spent two thirds of his or her remaining life in an institutional settings (including hospitals, LTACs and skilled nursing facilities).  One third died in an LTAC, never returning home.

So you would think with this population of older people with serious illness and a shorter prognosis than many cancers, we would have robust geriatrics and palliative care in LTACs?  Right? Wrong.

3% were seen by a geriatrici…

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…